Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer

NCT02383251 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Pazopanib
DRUG: Paclitaxel

Sponsor

ARCAGY/ GINECO GROUP

Collaborators

[object Object]